Products mRNA-1273 enters the market as a white dispersion in multidose containers. It was licensed in the EU on January 6, 2021, and in many countries on January 12, 2021. The vaccine has been studied in a clinical trial involving more than 30,000 participants. The unopened multi-dose vial can be stored at -15 °C to … MRNA-1273
Products BNT162b2 from German biotechnology company BioNTech and Pfizer was approved in many countries on December 19, 2020, as the first representative of mRNA vaccines and Covid-19 vaccines (Comirnaty, frozen suspension). The vaccine was studied in 2020 in a large Phase III trial with more than 44,000 participants. Switzerland was the first country in which … BNT162b2 (Tozinameran)
